Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23372680 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Use of Anti-oxidants to Reduce Sequela of Mild Traumatic Brain Injury (mTBI) After Blast Exposure
Condition: Mild Traumatic Brain Injury
Interventions: Drug: N-acetyl-cysteine (NAC);   Drug: Placebo

Indicates status has not been verified in more than two years